Mrs. Sandra Marie Flanagan, RN, BSN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 92023 Purkerson Rd, Junction City, OR 97448 Phone: 503-294-1006 Fax: 503-294-1006 |
Connie Ruth Burns, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24774 Lavell Rd, Junction City, OR 97448 Phone: 541-521-3452 |
Lisa D Grissell, Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 25701 Hall Rd, Junction City, OR 97448 Phone: 541-998-6268 |
Bethany Grace Aberle, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 E 6th Ave, Junction City, OR 97448 Phone: 541-226-7236 |
Mrs. Leighanne B Mcgowan, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 91648 River Rd, Junction City, OR 97448 Phone: 503-319-2426 Fax: 541-461-2498 |
Natalya L Mortimer, ARNP, PMHNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 29398 Recovery Way, Junction City, OR 97448 Phone: 541-465-2554 |
Heather Marie Howell, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 92231 Applegate Trl, Junction City, OR 97448 Phone: 541-510-7090 |
News Archive
Up to 40 percent of eyeglass wearers are interested in self-tinting lenses, according to an international Carl Zeiss Vision study of 5,800 eyeglass wearers. Yet despite high consumer interest, only about 20 percent of eyeglass wearers purchase self-tinting lenses. Many consumers hold back because they want lenses that darken and clear faster. To meet this need, ZEISS, a leader in precision optics for over 160 years, has introduced a new self-tinting lens called PhotoFusion.
When most people discover mold on their bread, they immediately throw it out. Others see a world of possibilities in the tiny fungus. A University of Missouri scientist, along with a collaborative research team, has examined a new mechanism in the reproductive cycle of a certain species of mold.
Perceived limitations in walking ability among patients who experience stroke can be assessed using the Walking Impact Scale, show study findings.
UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C'Nano which was held in Dijon in early December.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
› Verified 5 days ago